Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

Faizan Khan, Alvi Rahman, Marc Carrier, Clive Kearon, Jeffrey I. Weitz, Sam Schulman, Francis Couturaud, Sabine Eichinger, Paul A. Kyrle, Cecilia Becattini, Giancarlo Agnelli, Timothy A. Brighton, Anthonie W. A. Lensing, Martin H. Prins, Elham Sabri, Brian Hutton, Laurent Pinede, Mary Cushman, Gualtiero Palareti, George A. WellsPaolo Prandoni, Harry R. Buller, Marc A. Rodger*, MARVELOUS Collaborators

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number4363
Number of pages12
JournalBMJ (e)
Volume366
DOIs
Publication statusPublished - 24 Jul 2019

Keywords

  • DEEP-VEIN THROMBOSIS
  • PULMONARY-EMBOLISM
  • ORAL ANTICOAGULATION
  • EXTENDED TREATMENT
  • THERAPY
  • EPISODE
  • WARFARIN
  • ASPIRIN
  • RIVAROXABAN
  • PREVENTION

Cite this